A separate prescription discussion, not a substitute for an approved obesity medicine.
CoreAge Rx advertises sermorelin starting at $99 per month on a treatment-specific product page. That public offer establishes what the provider markets, not that a particular reader needs the therapy or will receive a promised aging or body-composition benefit.
This page includes the verified offer without padding the list with clinics whose sermorelin details were not confirmed. Sermorelin should not be counted as a proven substitute for an approved weight management drug. The clinical objective and prescription require their own discussion.
Advertised sermorelin
A stated monthly compounded-medicine price, with important prescription and refund checkpoints.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Ask what the prescribing clinician is trying to address, what evidence supports the proposal, and which uncertainties remain. Broad longevity language or a favorable provider testimonial is not individualized medical evidence. Bring a complete history to the clinical assessment.
Confirm the formulation, dispensing pharmacy, quantity, handling directions, monitoring, and full recurring cost. The CoreAge Rx review describes the provider’s broader process and refund checkpoints. Its GLP-1 offers should not be used to infer the sermorelin prescription or supply terms.
Explore the review directory and full cost table to compare the details of another offer.
Official public information reviewed October 1, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.
Build a useful comparison from the next invoice, not the smallest number on the page.
Read the guide →The ingredient name is the beginning of the medicine discussion, not the complete answer.
Read the guide →Bring the information that turns an online assessment into a useful medical discussion.
Read the guide →